Filtered By:
Source: Journal of Vascular Surgery
Condition: Heart Attack

This page shows you your search results in order of date.

Order by Relevance | Date

Total 87 results found since Jan 2013.

Angiotensin-converting Enzyme Inhibitors and Angiotensin Receptor Blockers are Associated With Improved Amputation Free Survival in Chronic Limb-threatening Ischemia
In the Heart Outcomes Prevention Evaluation (HOPE) study, investigators found that ramipril was associated with improved survival as well as decreased myocardial infarction (MI) and stroke rates in patients with peripheral arterial disease. Nonetheless, their effect on chronic limb-threatening ischemia (CLTI)-specific outcomes is unclear. We aim to assess the effect of angiotensin-converting enzyme inhibitors/angiotensin receptor blockers (ACEIs/ARBs) on amputation-free survival in patients with CLTI undergoing peripheral vascular intervention (PVI) in a Medicare-linked database.
Source: Journal of Vascular Surgery - August 18, 2023 Category: Surgery Authors: Nadin Elsayed, Darrin Clouse, Raghu L. Motaganahalli, Mahmoud Malas Source Type: research

General Anesthesia Does Not Increase Mortality and Morbidity in High-risk Patients Undergoing Carotid Endarterectomy
Myocardial infarction and stroke are known complications of general anesthesia, resulting in the effort to perform carotid endarterectomy (CEA) for high-risk patients under local/regional anesthesia. However, there are few data supporting this practice.
Source: Journal of Vascular Surgery - May 23, 2023 Category: Surgery Authors: Emanuela C. Peshel, Renxi Li, Yan Cheng, Jamie Thompson, Salim Lala, Anton Sidawy, Bao-Ngoc Nguyen Tags: SVS-VESS Scientific Session @ VAM: Session 1 Source Type: research

Angiotensin-converting Enzyme Inhibitors and Angiotensin Receptor Blockers Are Associated With Improved Amputation-free Survival in Chronic Limb-threatening Ischemia
Angiotensin-converting enzyme inhibitors (ACEIs) and angiotensin receptor blockers (ARBs) are known to decrease cardiovascular morbidity and mortality in patients with atherosclerotic disease. In the Heart Outcomes Prevention Evaluation (HOPE) study, investigators found that ramipril was associated with improved survival as well as decreased myocardial infarction (MI) and stroke rates in patients with peripheral arterial disease. Nonetheless, their effect on chronic limb-threatening ischemia (CLTI)-specific outcomes is unclear.
Source: Journal of Vascular Surgery - May 23, 2023 Category: Surgery Authors: Nadin Elsayed, Darrin Clouse, Raghu L. Motaganahalli, Mahmoud Malas Tags: International Poster Competition Source Type: research

Transcarotid Artery Revascularization Sustains Its Advantage Over Transfemoral Carotid Artery Stenting in the Longer Term: Propensity Score-Matched Three-Year Outcomes
The superiority of transcarotid artery revascularization (TCAR) over transfemoral carotid artery stenting (TFCAS) has been established in the perioperative period with a lower risk of stroke and death. However, it remains unclear whether TCAR will sustain its advantage in the longer term. We evaluated the 3-year outcomes for death, transient ischemic attack (TIA), stroke, and myocardial infarction (MI) after TCAR and TFCAS.
Source: Journal of Vascular Surgery - March 17, 2023 Category: Surgery Authors: Jerry Zhu, Ajit Rao, Daniel Han, Ageliki Vouyouka, Windsor Ting, David Finlay, Sung Yup Kim, Rami Tadros, Michael Marin, Peter Faries Source Type: research

Association of Beta Blockers and Calcium Channel Blockers with Arrhythmia After Carotid Intervention
Postoperative arrhythmia has a reported incidence of 2% to 4%, which can increase patients ’ risk of developing stroke or myocardial infarction; however, insufficient data are available regarding the prognostic implications and management of arrhythmia after carotid intervention. The aim of this study was to identify the factors associated with arrhythmia after carotid intervention usin g data collected as a part of the Society for Vascular Surgery Vascular Quality Initiative.
Source: Journal of Vascular Surgery - March 17, 2023 Category: Surgery Authors: Teah Qvavadze, Fedor Lurie, Todd Russell Source Type: research

Physiologic Risk Factors Increase Risk of Myocardial Infarction with TransCarotid Artery Revascularization in Prospective Trials
ObjectivePatients may be considered at high risk for CEA due to either anatomical or physiologic factors and are often treated with TCAR. Patients with physiologic criteria are deemed to have higher overall surgical risk due to more significant comorbidities. Our aim is to study the incidence of stroke, myocardial infarction (MI), death, and combined endpoints in patients who underwent TCAR comparing ANAT vs. PHYS risk factors.MethodsAn analysis of the prospectively collected data from the ROADSTER (pivotal), ROADSTER2 (FDA indicated post-market), and ROADSTER Extended Access TCAR trials was performed.
Source: Journal of Vascular Surgery - December 20, 2022 Category: Surgery Authors: Jane Chung, Norman H. Kumins, Justin Smith, Raghu L. Motaganahalli, Peter A. Schneider, Christopher J. Kwolek, Vikram S. Kashyap, ROADSTER Investigators Source Type: research

Factor Xa Inhibitor in Peripheral Revascularization: A Vascular Quality Initiative Analysis
Adding rivaroxaban to standard antiplatelet therapy has been shown to reduce mortality from cardiovascular causes, myocardial infarction (MI), stroke, and lower acute limb ischemia (ALI). To determine the generalizability of these results and assess the effects of adding a factor Xa inhibitor (FXI) to antiplatelet therapy in peripheral revascularization, an analysis was conducted with a large, multinational database.
Source: Journal of Vascular Surgery - May 19, 2022 Category: Surgery Authors: Lucy Yang, Dillon M. Gibson, Anuja Sarode, Benjamin Colvard, Jun Li Tags: PC: Poster Competition Source Type: research

Statins Decrease Risk of Amputation in Patients Undergoing Lower Extremity Open Revascularization Procedures
The objective of this study was to determine the effect of statins on amputation risk and major adverse cardiac events (defined as the composite of myocardial infarction, stroke, and death) in patients with PAD undergoing open lower extremity revascularization.
Source: Journal of Vascular Surgery - May 19, 2022 Category: Surgery Authors: Sungshin Amy Na, Natale Mazzaferro, William E. Beckerman Tags: PC: Poster Competition Source Type: research

Dialysis-dependent Patients Have Increased Risk of Myocardial Infarction and Perioperative Death Following Carotid Revascularization Using Transcarotid Artery Revascularization
Dialysis-dependent patients have been reported to have high rates of stroke and death following carotid revascularization; however, recent data suggests that outcomes for the treatment of carotid stenosis in dialysis-dependent patients may be better than previously surmised. The effect of dialysis dependence on outcomes following transcarotid artery revascularization (TCAR) remains unclear. We aimed to study outcomes following the treatment of symptomatic and asymptomatic carotid stenosis using TCAR among dialysis-dependent patients.
Source: Journal of Vascular Surgery - May 19, 2022 Category: Surgery Authors: Nallely Saldana-Ruiz, Myra Ahmad, Sarah E. Deery, Marc L. Schermerhorn, Peter A. Soden, Matthew Smith, Niten Singh, Sara L. Zettervall Tags: PC: Poster Competition Source Type: research

Physiologic Risk Factors Increase the Risk of Myocardial Infarction but Not Stroke or Death After Transcarotid Artery Revascularization in Prospective Trials
Current high-risk criteria to undergo transcarotid artery revascularization (TCAR) are categorized into anatomical (ANAT) and physiologic (PHYS) factors. Patients with physiologic criteria are deemed to have higher overall surgical risk due to more significant comorbidities. Our aim is to study the incidence of stroke, myocardial infarction (MI), death, and combined end points in patients who underwent TCAR comparing ANAT vs PHYS risk factors.
Source: Journal of Vascular Surgery - May 19, 2022 Category: Surgery Authors: Jane Chung, Norman H. Kumins, Raghu L. Motaganahalli, Peter A. Schneider, Christopher Kwolek, Vikram S. Kashyap Tags: VESS Paper Session Source Type: research

Revascularisation for Symptomatic Peripheral Artery Disease: External Applicability of the VOYAGER PAD Trial
This study described the proportion of patients eligible for VOYAGER PAD within the nationwide Danish Vascular Registry (DVR), reasons for ineligibility, and outcomes according to eligibility.
Source: Journal of Vascular Surgery - February 18, 2022 Category: Surgery Authors: M. S øgaard, P.B. Nielsen, F. Skjøth, T.B. Larsen, N. Eldrup Source Type: research

Commentary
I have often said to interested trainees and students that vascular surgery is about women's health. Evidence suggests that cardiovascular disease affects women differently —the symptoms of myocardial infarction are often “atypical” in women. The number of hospital discharges for heart failure and stroke are higher in women than in men.1 When detected in women, abdominal aortic aneurysms are often anatomically unsuitable for commercially available endovascular de vices, and mortality is higher from either open or endovascular surgery.
Source: Journal of Vascular Surgery - December 20, 2021 Category: Surgery Authors: Ulka Sachdev-Ost Tags: Invited commentary Source Type: research

Reply
We would like to thank Lazarides et  al in their letter to the editor regarding our report “Literature Review of Primary versus Patching versus Eversion as Carotid Endarterectomy Closure.”1 We agree with most of their comments. However, we did include a meta-analysis by Texakalidis et al.2 They had performed a meta-analysis of r andomized trials comparing bovine pericardium and other patch materials for carotid endarterectomy (CEA), which showed that the incidence of 30-day stroke, myocardial infarction, wound infection, death, cranial nerve injury, carotid artery thrombosis, and death were comparable.
Source: Journal of Vascular Surgery - September 29, 2021 Category: Surgery Authors: Ali F. AbuRahma, R. Clement Darling Tags: Letter to the Editor Source Type: research

Cost Comparison of Transcarotid Arterial Revascularization With Carotid Endarterectomy and Transfemoral Carotid Stenting
Transcarotid arterial revascularization (TCAR) has been associated with a lower risk of stroke or death compared with transfemoral carotid artery stenting (TFAS) and a lower risk of cranial nerve injury and myocardial infarction than carotid endarterectomy (CEA). To the best of our knowledge, no comparative studies have been performed of the costs between TCAR, CEA, and TFAS, which could have important implications on institutional support for the new modality to address carotid artery stenosis.
Source: Journal of Vascular Surgery - September 29, 2021 Category: Surgery Authors: John J. Kanitra, Isabella Graham, David R. Hayward, Richard Berg, Jimmy Haouilou Source Type: research

Increased Stroke Severity, ST-elevation Myocardial Infarction, Type A Aortic Dissection, and Deaths at Home in an Early Epicenter of the Coronavirus Disease 2019 Pandemic
The effect of the coronavirus disease 2019 (COVID-19) pandemic on conditions other than COVID-19 has been difficult to quantify. Early reports suggested widespread delays in acute care; however, the extended effects of the pandemic on life-threatening conditions has not been reported. We evaluated the ongoing effects of the COVID-19 pandemic on cardiovascular pathology at a tertiary care hospital.
Source: Journal of Vascular Surgery - August 24, 2021 Category: Surgery Authors: Clayton J. Brinster, Gabriel Vidal, James Jenkins, Aditya Bansal, Ross Parkerson, Charles Leithead, Hernan Bazan, Samuel R. Money, Chip Sternbergh Tags: Special Session: COVID-19 Source Type: research